Michael Guth Email & Phone Number
Senior Director, Translational Medicine and AI; Head of AI-Enabled Drug Development @ Institute for Neuroplasticity Research
5 free lookup(s). No credit card required.
If you need more lookups,
subscriptions start at $34 USD/month.
Michael Guth Location
- Oak Ridge, TN, US
Michael Guth Work
- 2002 -now Senior Director, Translational Medicine and AI; Head of AI-Enabled Drug Development @
- 2023 -2023 Representative Regulatory Medical Writing Project @
- 2022 -2022 Medical Communications (Journal and Conference Publications) Project @
- 2020 -2021 Representative Projects (Neurovascular Devices and Software as a Medical Device SaMD) @
- 2010 -2022 REAL-WORLD EVIDENCE (RWE) Services Provided @
- 2020 -2021 Representative consulting project @
Michael Guth Education
- California Institute of Technology
M.S. (Social Science (Quantitative Modeling))
- Taft Law School
- Rice University
B.A. (Economics (major), Space Physics)
- Tennessee, University of
Ph.D. (Economics)
- Tennessee, University of
J.D. (law)
Michael Guth Skills
- Clinical Data Analysis
- Risk-benefit Analysis
- Side Effects and Corticosteroid treatment
- hepatocellular cardinoma
- Gastric Cancer Gastroesophageal Junction Adenocarcinoma
- Principal Investigator
- Health Economics and Outcomes Research
- Medical Journal Article Writing and Editing
- Annual Reports
- Identifying Issues
- Document Preparation
- clinical protocols Protocol Amendments Investigator Brochure (IB) Fast Track Request Orphan Drug Designation (ODD)
- obesity glucagon-like peptide-1 ( GLP-1) glucose-dependent insulinotropic polypeptide (GIP) Tirzepatide semaglutide selective activin receptor ligand trap
- Clinical Evaluation Report (CER) Summary of Safety and Clinical Performance (SSCP) Clinical Study Reports (CSRs)
- cancer treatment, proteolysis targeting chimeric (PROTAC) technology ubiquitin-proteasome system (UPS) natural degradation disease-causing proteins
- Radiopharmaceuticals Radionuclides Alpha-radiation Theranostics
- proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors Angiopoietin-like protein 3 (ANGPTL3) inhibitor drugs
- Good Publication Practices (GPP3 GP 2022) scientific publication plans Medical Journal articles
- Advertising & Promotional Materials Regulatory Affairs
- Endocrinology, Hormone Replacement Therapy, Thyroid Hormones, Testosterone, Estrogen
- Population Health, Epidemiology, Real-World Data (RWD)
- Center for Medicare and Medicaid Services (CMS) Center for Disease Control (CDC)
- US FDA Briefing Documents, Regulatory Responses, Risk Management Plans (RMP), Risk Management Report (RMR)
- Edit Clinical overview (Module 2.5), Clinical summary of efficacy (Module 2.7.3), Clinical summary of safety (Module 2.7.4)
- Integrated summary of efficacy (Module 5.3.5.1) Integrated summary of safety (Module 5.3.5.2)
- Observational Studies, Registry Studies, Real-World Evidence Studies, post-marketing surveillance
- Pre-clinical in vitro and in vivo studies
- Clinical Pharmacology, PB/PK/PD, PopPK, Pharmacometrics studies
- Health Economics and Claims Analysis
- gene therapy, cell therapy, biologics
- Software as a Medical Device (SaMD)
- Investigational New Drug Application (IND)
- Product Launch
- Neurodegenerative Disease
- Combination Products
- Pharmaceuticals
- Skin Cancer
- Diabetes
- Predictive Modeling
- Patient Reported Outcomes
- Nutrition
- Immuno-oncology
- Strategy
- Clinical Research
- Medical Writing
- Clinical Trials
- Regulatory Affairs
- Prevention
- Healthcare Information Technology
- Healthcare Consulting
- HIPAA
- regulatory medical writing
- Financial Advisory
- Market
- Arrangements
- Undergraduate
- Cost
- Students
- Mentoring
- Frameworks
- EHR
- Cost Effective
- Non Technical
- Business Partners
- Bear
- Directs
- Summa Cum Laude
- Article
- Robotics
- Webinars
- Design
- Safety Regulations
- Allocations
- Programmers
- Human Resources
- Bonds
- Distribution Strategies
- Interdisciplinary Teaching
- Capital Markets
- System
- Staff Management
- Reactor
- Physician Relations
- Equation
- Strategies
- Lasting Relationships
- Medicine
- Risk Management
- Policy
- Employee Training
- Strive For Excellence
- Contract Negotiation
- Documentation
- Project Management
- Organizational Design
- Capital
- Lessons Learned
- Middle Office
- Quantitative Investing
- Magnitude
- Drawing
- Hospitals
- Network Contracting
- Platinum
- Cash Flow
- Project Reviews
- Logistics
- Swaps
- Floors
- Business Development
- Medical Facilities
- Communication
- Modeling
- Negotiation
- Efficacy
- Discern
- Scientific
- Safety
- Privacy Law
- Contingent
- Claims Resolution
- Marketing
- Leadership Development
- Business Alliances
- At Risk
- Facilities Management
- Intellectual Property
- Healthcare Management
- Board Level
- Responsibility
- Usa
- Policies and Procedures
- Regulations
- Magazines
- Structured Finance
- Teaching
- Tax Law
- Tax
- Medical Centers
- Environmental Remediation
- Claim
- ACA
- Delivering Presentations
- Compliance
- Canada
- Proposal Writing
- Pharmaceutics
- Judges
- Interest Rates
- Disputes
- Operational Risk
- Invoicing
- Pharmacoeconomics
- Quantitative Risk
- Client Presentation
- Risk
- Trading
- Filing
- ERISA
- FDA
- Joint Ventures
- Uncertainty
- Credit Derivatives
- Writing
- Capital Structure
- Oklahoma
- RAROC
- Payments
- Overseeing
- Leases
- Phase Ii
- Finance
- Healthcare Information
- Gold'S Gym
- Portfolio Risk
- Occasion
- Regulatory Compliance
- Trading Floors
- Global Economics
- Competition Law
- Monitoring Progress
- Vertical Integration
- Employment Contracts
- War Gaming
- Circumstances
- Wellness
- Auditing
- Liaising
- Basel II
- Wellness Visit
- Guidance
- Statutory
- Physicians
- Forecasting
- Engineering
- Reports
- Extensions
- Public Health
- Cash Flow Forecasting
- Capitalization
- System Operations
- Testing
- Asset Management
- Pricing Strategy
- Payors
- Editing
- Audience
- Market Risk
- News
- Conferences
- Research
- Articles
- Investigation
- Gas Turbines
- Loans
- Partnerships
- Tension
- Written
- P&L
- Gamma
- Power
- Operations Research
- Rice
- Osteoporosis
- Houston
- Corporate Finance
- Space
- Dossiers
- Energy
- Differential
- Bulletins
- Case Studies
- Risk Assessment
- Peer Reviews
- Catastrophic
- Drafting
- Project Planning
- Nursing Homes
- Succession Planning
- Golang
- Plants
- Interdisciplinary Research
- Anti Kickback Statute
- Losses
- Standardization
- Presentations
- Pricing
- Employment Law
- VAR
- COBRA
- Germany
- Reimbursement
- Taxations
- Solvency II
- 8 K
- Materials
- Presentations To Clients
- Equities
- Meteorology
- Stocks
- Cash
- Internal Controls
- Asset
- Theory
- Exotic Derivatives
- Light
- Budgets
- CAPM
- Academic Medical Centers
- Mergers and Acquisitions
- Evaluation
- Black Scholes
- Securities
- Strength Training
- Summarizing
- Units
- Medicare
- Enterprise Risk Management
- Software Selection
- Stark
- Net
- Articulate
- Pacific
- Credit Risk
- Lap Swimming
- Constructive
- Foreign Exchange
- Serving
- Metabolic Syndrome
- Construction
- Singapore
- Wound Care
- Professional Publications
- Benchmarking
- Texas
- Financial Statements
- Outsourcing
- German
- Journals
- Mathematical Economics
- Health Education
- Skype
- Transactional
- Rules
- Discrimination
- Health Law
- Physics
- Publications
- Cardio
- Algorithms
- Liquidity Risk
- Aluminum
- OTC
- Valuation
- Set Theory
- Compliance Plans
- Robot
- Build Relationships
- Training Seminars
- Healthcare
- Explaining
- Tests
- Utilization
- Continuing Legal Education
- Risk Measurement
- Medicare Advantage
- Cooperative
- Spread
- Practitioners
- Criminal Law
- Supplements
- Corporate Governance
- Quantitative Finance
- American
- Stakeholders
- Shares
- Power Trading
- Analysis
- Power Systems
- Solid Professional Standards
- Laboratory
- Commodities
- Transmission
- Health Economics
- Economics
- Gas
- Option Pricing Models
- Patient Reported
- Persuasiveness
- Rights
- Counterparty Risk
- New Business Opportunities
- Financial Modeling
- Graduate Level
- Licensure
- Foreign Languages
- False Claims
- Project
- Governance
- Sarbanes Oxley Act
- Contractual Agreements
- Delivers
- Drug Safety
- Quantitative Research
- Abuse
- Interpreting
- Equity Derivatives
- Independence
- Financial Audits
- Divestitures
- Health Care Reform
- Internal Audit
- Business Ethics
- Labor Issues
- Contract Management
- Presenter
- Portfolio
- Rural Development
- Private Clients
- Hazardous Waste Management
- Assemble
- Reviews
- Economists
- Investments
- Academic
- Patient Outcomes
- Outcomes Research
- Exotic
- Cost Efficiency
- Organizational Behavior
- Patient Care
- Financial Analysis
- Psychotherapy
- Trips
- Marking
- Scientists
- Population Health
- Conceptual Modeling
- Power Plants
- Employee Benefits
- Conclusions
- Constructive Feedback
- Administrative Law
- Arrow
- Greek
- Consulting
- Litigation
- Capital Management
- Vascular
- Poised
- Discover
- Health Care Fraud
- Insurance
- Manuscript
- Derivatives
- Structure
- Return on Investment
- Hyperlipidemia
- Lunch
- Arthritis
- Savings
- Option Valuation
- Real Estate
- Legal
- Law Enforcement
- Assessment
- Disease
- Management
- Diffuse
- Therapeutic Areas
- Securities Fraud
- General Electric
- Statistics
- Go To Person
- Boston
- Attorneys
- Ethics
- Public Speaking
- Execution
- Seminars
- Preventive Medicine
- Financial Economics
- Portfolio Management
- Languages
- Business Services
- Encouragement
- Disciplinary
- Project Finance
- Offering
- Default
- Organizational Restructuring
- Interest Rate Derivatives
- Managerial Economics
- Regulatory Capital
- Management Consulting
- Artificial Intelligence
- Computer Program
- Drug Delivery
- Approval Process
- Training
- Organizational Architecture
- Uncertainty Analysis
- Reporting
- R&D
- London
- Probability Theory
- Combination
- Concepts
- Segments
- Debt
- Health Policy
- Calm
- Control Environment
- Methodological
- Strategic Planning
- Institutions
- Partial
- Licensing
- Appearances
- Credit
- Electricity
- Difficult Situations
- Affordable Care Act
- Measurements
- House
- Oak
- FMLA
- Option Pricing
- Hedging
- Trading Floor
- Country
- Shareholder Value
- Internal Revenue Code
- Banking
- Conflicts
- Risk Management Consulting
- Art
- Commodity Markets
- Tax Exempt
- Executive Management
- Medical Ethics
- Immuno Oncology
- Internal Investigations
- Account Management
- Orange County
- Government
- Critique
- Software
- Limits
- Rate
- Topic
- Managed Care
- Art Exhibitions
- Endocrinology
- Decision Making
- Insurance Law
- Financial Transactions
- Pharmaceutical Industry
- Strategic Alliances
- Meetings
- French
- Traders
Michael Guth Summary
- Michael Guth, based in Oak Ridge, TN, US, is currently a Senior Director, Translational Medicine and AI; Head of AI-Enabled Drug Development at Institute for Neuroplasticity Research. Michael Guth brings experience from previous roles at Institute for Neuroplasticity Research. Michael Guth holds a M.S. in Social Science (Quantitative Modeling) @ California Institute of Technology. With a robust skill set that includes Clinical Data Analysis, Risk-benefit Analysis, Side Effects and Corticosteroid treatment, hepatocellular cardinoma, Gastric Cancer Gastroesophageal Junction Adenocarcinoma and more. Michael Guth has 1 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Michael Guth?
Find contact details for 700 million professionals.
Others Named Michael Guth
Michael Guth
President
Milwaukee, WI, US
Michael Guth
Project Quality Manager
Sheffield, GB
Michael Guth
Real Estate Agent
Merritt Island, FL, US
Michael Guth
Managing Partner
New York, NY, US
Michael Guth
Hydrogen Markets Business Development Manager
Somerville, NJ, US
Top Institute for Neuroplasticity Research Employees
G2 Crowd Trusted
300K+ Plugin Users
© 2026 RocketReach.co